Lefamulin is a semi-synthetic pleuromutilin antibiotic derived from the fungus Pleurotus mutilus. It is designed for systemic administration and features a novel mechanism of action that shows benefit against resistant bacteria causing community-acquired pneumonia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1061337-51-6
Risperidone
pharmaceutical raw material
Rufinamide
pharmaceutical raw material
Tamsulosin hydrochloride
pharmaceutical raw material
Faropenem
pharmaceutical raw material
Lefamulin acetate
pharmaceutical raw material
[(1S,2R,3S,4S,6R,7R,8R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[(1R,2R,4R)-4-amino-2-hydroxycyclohexyl]sulfanylacetate
KPVIXBKIJXZQJX-CSOZIWFHSA-N
C[C@H]1[C@@H]([C@](C[C@H]([C@]2([C@H]3[C@@]1(CCC2C)CCC3=O)C)OC(=O)CS[C@@H]4CC[C@H](C[C@H]4O)N)(C)C=C)O